Prevena
Device
KCI USA, Inc
Total Payments
$875,369
Transactions
43
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $875,369 | 43 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $874,619 | 42 | 99.9% |
| Education | $750.00 | 1 | 0.1% |
Payments by Type
Research
$874,619
42 transactions
General
$750.00
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| The Management of Closed Surgical Incisions Resulting from Incisional Hernia Repair and or Functional Panniculectomy Using the Prevena Customizable Dressing | KCI USA, Inc | $492,625 | 0 |
| Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site infection in Human Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery | KCI USA, Inc | $159,029 | 0 |
| Mechanical Forces to Augment Fat Grafting 3 year study | KCI USA, Inc | $53,856 | 0 |
| A Randomized Control Trial of Prevena Peel & Place Dressings versus Standard Closure for Patients Undergoing Pancreaticoduodenectomy Who Have Undergone Neoadjuvant Chemotherapy or Biliary Stent Placement | KCI USA, Inc | $49,893 | 0 |
| Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean a multicenter Randomized Trial | KCI USA, Inc | $40,200 | 0 |
| Randomized Controlled Trial of Wound Management with Negative Pressure Dressing Versus Standard Dressing After Revision Arthroplasty | KCI USA, Inc | $21,218 | 0 |
| Comparison of Negative Pressure Wound Therapy versus Conventional Dressings for the Prevention of Wound Complications following Revision Total Hip Arthroplasty A Prospective, Randomized, Controlled Trial | KCI USA, Inc | $15,959 | 0 |
| Negative pressure wound therapy in post-operative incision management | KCI USA, Inc | $13,000 | 0 |
| Use of Prevena Incision Management System in Wound Morbidity In Complex Ventral Hernia Patients. A Prospective Randomized Controlled Trial | KCI USA, Inc | $12,000 | 0 |
| KCI.PREVENA.2017.01 Post-market, Randomized, Open-Label, Multicenter. Study to Evaluate the Effectiveness of Closed Incision Negative Pressure Therapy Versus Standard of Care Dressings In Reducing Surgical Site Complications in Subjects with Revision of a Failed Total Knee Arthroplasty PROMISES | KCI USA, Inc | $10,500 | 0 |
| A Prospective Observational Study of the use of Negative Pressure Wound Therapy in High Risk Abdominal Closed Incisions | KCI USA, Inc | $4,329 | 0 |
| Negative Pressure Wound Therapy for Surgical Incision Management following Total Hip Arthroplasty | KCI USA, Inc | $2,010 | 0 |
Top Doctors Receiving Payments for Prevena
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Pineville, LA | $875,369 | 43 |
Ad
Manufacturing Companies
- KCI USA, Inc $875,369
Product Information
- Type Device
- Total Payments $875,369
- Total Doctors 0
- Transactions 43
About Prevena
Prevena is a device associated with $875,369 in payments to 0 healthcare providers, recorded across 43 transactions in the CMS Open Payments database. The primary manufacturer is KCI USA, Inc.
Payment data is available from 2017 to 2017. In 2017, $875,369 was paid across 43 transactions to 0 doctors.
The most common payment nature for Prevena is "Unspecified" ($874,619, 99.9% of total).
Prevena is associated with 12 research studies, including "The Management of Closed Surgical Incisions Resulting from Incisional Hernia Repair and or Functional Panniculectomy Using the Prevena Customizable Dressing" ($492,625).